speaker-icon

Latest Posts

Innoplexus-AIO-partnership

2

Jan 24

Innoplexus and AIO Studien gGmbH are jointly announcing the start of a pilot project as part of the AIO data hub initiative

January 02, 2024 - Innoplexus and Amrit AG, members of the Partex NV Group, providers of innovative technology for health...
Read More
anavex_partex_partnership_Innoplexus

27

Jun 23

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More
CEO and Founder Gunjan Bhardwaj, PhD On Driving Innovation and Ensuring Success

CEO and Founder Gunjan Bhardwaj, PhD On Driving Innovation and Ensuring Success

Gunjan Bhardwaj is the Founder and CEO of the Innoplexus group. He was earlier with the Boston Consulting Group and before that the leader of the global business performance think-tank of Ernst & Young and a manager in the German practice with a solution focus on strategy and innovation.

He has led projects in strategy, analytics and technology for various clients in different parts of the world. Gunjan was also a partner, senior-editor and advisor for a prominent online innovation management journal and was a member of the scientific advisory board of a US based not for profit institute researching in complexity sciences in the healthcare industry.

Innoplexus is at the forefront of decision-making technology as the company works in data aggregation to provide to researchers, pharmaceutical companies, hospitals, and more. CEO and Founder Gunjan Bhardwaj, PhD, focuses his effort on managing exploratory and exploitative innovation. He recognizes the issue of security and data sharing in the EU and Innoplexus has taken advantage of the opportunity to make as much life science data available to his clients while aligning with GDPR. Find out in this next video about the three things his company does to ensure success.

The original article was published on Bizcast.

Featured News

new_app_cancer_patients

New app for cancer patients

Das Eschborner Unternehmen Innoplexus hat eine neue App namens „Curia“ für Krebspatienten veröffentlicht. Mit dem Computerprogramm, das sich unentgeltlich herunterladen…